Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cancer: Breakthrough Pain × Ketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 10 Neoplasms 10 Pain, Postoperative 9 Agnosia 8 Depression 7 Breast Neoplasms 7 Head and Neck Neoplasms 5 Chronic Pain 4 Anxiety Disorders 4 Pancreatic Neoplasms 3 Pain, Intractable 3 Colorectal Neoplasms 3 Acute Pain 3 Prostatic Neoplasms 2 Gastrointestinal Neoplasms 2 Cancer Pain 2 Stomatitis 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Analgesia 1 Peripheral Nervous System Diseases 1 Pelvic Neoplasms 1 Pain, Procedural 1 Otolaryngeal Cancer 1 Neurotoxicity Syndromes 1 Mucositis 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Laparoscopic Colorectal Resection Due to Cancer 1 Ileus 1

Interventions

Morphine 1 Ketamine 1 Chitosan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02591017 2018-11-13

ONKEMI

University Hospital, Basel, Switzerland

Phase 3 Terminated

Cancer: Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡